Samsung Biologics Co Ltd
KRX:207940
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Samsung Biologics Co Ltd
KRX:207940
|
KR |
|
Althea Group Holdings Ltd
ASX:AGH
|
AU |
|
360 Ludashi Holdings Ltd
HKEX:3601
|
CN |
|
AEye Inc
NASDAQ:LIDR
|
US |
|
CVS Health Corp
NYSE:CVS
|
US |
|
Daiwa House Industry Co Ltd
TSE:1925
|
JP |
|
Achieve Life Sciences Inc
NASDAQ:ACHV
|
US |
|
V
|
VTM Ltd
BSE:532893
|
IN |
|
Huanxi Media Group Ltd
HKEX:1003
|
HK |
|
I
|
International Conveyors Ltd
NSE:INTLCONV
|
IN |
|
Viva Goods Co Ltd
HKEX:933
|
HK |
|
Torque Metals Ltd
ASX:TOR
|
AU |
Bankruptcy Probability
Samsung Biologics Co Ltd's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Samsung Biologics Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
865.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
295.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Baxter International Inc
NYSE:BAX
|
8.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
972B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
184.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Danaher Corp
NYSE:DHR
|
132.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Lonza Group AG
SIX:LONN
|
32.7B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
268B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Agilent Technologies Inc
NYSE:A
|
31.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Samsung Biologics Co Ltd's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Samsung Biologics Co Ltd has total debt of 1T KRW. This includes both short-term (152B KRW) and long-term (896.1B KRW) debt.
You can find a full breakdown on its Balance Sheet.
